Moreover, as the majority of human prostate adenocarcinomas have this mature luminal phenotype, characterized by expression of cytokeratins 8/18, AR and prostate-specific antigen (PSA), the assumption has been that the cell of origin of prostate cancer is the differentiated secretory luminal cell. The gene discussed is AR; the disease is prostate carcinoma.